Clinical Trial Update: Study of Bendamustine Hydrochloride for the Treatment of Pediatric Patients With Relapsed or Refractory Acute Leukemia [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/Phase 2 pediatric study evaluated bendamustine hydrochloride in children with relapsed or refractory acute leukemia, with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• Treanda (Bendamustine)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-10-01